.75 semaglutide side effects of Wegovy Explained Frontiers | Safety of Semaglutide

Tirzepatide (Mounjaro/Zepbound) Tirzepatide is a dual GIP/GLP-1 receptor agonist that produces even greater weight loss than Semaglutide (average 20-22% of body weight)

Concurrently, it inhibits the secretion of glucagon, a hormone that increases blood glucose levels, thereby addressing hyperglycemia from both sides of the metabolic equation

The maximum maintenance dose for diabetes is currently 14 mg daily

As an incretin mimetic, semaglutide is a very effective weight-loss medication

This pattern differs from conditions such as alopecia areata or androgenetic alopecia, which have distinct presentations and underlying mechanisms

How these differ from brand-name Mounjaro Brand-name Mounjaro (manufactured by Eli Lilly) contains only tirzepatide